44M 19 months fin oral 1mg daily /min 5% foam once daily
    Progress Pictures 6/7/2025

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Ketoconazole →

    Antifungal, best known as a dandruff shampoo

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily 19 months
    💧 Minoxidil (topical) 5% foam once or twice daily 19 months
    💧 Nizoral (topical) occasionally
    the tone is 😐 neutral with mixed results.

    Other terms

    A 44-year-old man has been using finasteride 1mg daily and minoxidil 5% foam for 19 months to address hair loss, with mixed results and continued shedding. Suggestions include trying oral minoxidil, microneedling, and possibly a hair transplant for better cosmetic density.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Current and Emerging Approaches to Androgenetic Alopecia

      January 2026 in “Dermatology Review”
      This review discusses androgenetic alopecia, outlining its genetic and hormonal causes, and summarizes current and emerging treatments like minoxidil, finasteride, and low-dose oral therapies, emphasizing the need for more research to confirm the efficacy and safety of newer approaches.

      research Guidelines based management of androgenetic alopecia

      January 2014 in “Cosmoderma”
      This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.

      research Male Androgenetic Alopecia - A Review of Current Treatments

      February 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
      This study reviewed treatments and findings related to male androgenetic alopecia, noting that topical minoxidil and oral finasteride are effective for slowing hair loss, while newer interventions like PRP and microneedling show promise.